Charles River Laboratories CRL Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableGrossCurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's accounts receivable?
- Charles River Laboratories (CRL) reported accounts receivable of $708.37M in Q1 2026.
- How has Charles River Laboratories's accounts receivable changed year-over-year?
- Charles River Laboratories's accounts receivable decreased by 8.3% year-over-year, from $772.89M to $708.37M.
- What is the long-term trend for Charles River Laboratories's accounts receivable?
- Over 5 years (2020 to 2025), Charles River Laboratories's accounts receivable has grown at a 2.9% compound annual growth rate (CAGR), from $624.44M to $719.32M.
- What does accounts receivable mean?
- The amount of money customers owe the company for services provided, minus expected bad debts.
- How do you interpret accounts receivable?
- A rising balance relative to revenue may signal collection delays or credit risk, while a falling balance suggests efficient cash conversion.
- How does accounts receivable compare across companies?
- Standard across service-based industries; high levels relative to peers can indicate aggressive revenue recognition or collection issues.